ReviewTherapeutic advances in hematology2021
The role of carfilzomib in relapsed/refractory multiple myeloma.
Andrew J YeePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ReviewTherapeutic advances in hematology2021
Andrew J YeePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.